RPRX EPS Estimates
Royalty Pharma plc
$60.96
+$1.34(+2.25%)
80
Overall
100
Value
90
Tech
52
Quality
Market Cap
$35.05B
Volume
5.79M
52W Range
$35.92 - $64.38
Target Price
$66.00
RPRX EPS estimates: the consensus estimate for Royalty Pharma plc's current fiscal year is $5.32 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RPRX EPS Estimates
- EPS estimate, current quarter
- $1.18
- EPS estimate, next quarter
- $1.53
- EPS estimate, current year
- $5.32
- EPS estimate, next year
- $5.56
- EPS growth, 3-year
- +161.59%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.79 |
| 2024 | $1.92 |
| 2023 | $2.54 |
| 2022 | $0.10 |
| 2021 | $1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $60.96 | +2.2% | 5.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |